Passer au contenu de la page principale

James Whelan

Participe à 6 sessions

Dr. Whelan was born in St. John’s, Newfoundland and completed his Undergradute Degree in Physics and his Medical Degree at Memorial University. He completed a 4 year Residency in Ophthalmology at Dalhousie University in Halifax, Nova Scotia. He then completed a 2 year fellowship in Medical and Surgical training in diseaes of the Retina,Vitreous and Intraocular Tumors at Wills Eye Hospital in Philadelphia Pennsylvania. 

Dr. Whelan is currently an Assistant Professor, and Retina Surgeon for  the Department of Surgery at Memorial University of Newfoundland. He is a staff Retina Surgeon for the Eastern Health Corporation at the Health Science Center and Janeway Child Health Center in St. John’s.  He is  Past President of the Candian Retina Society, and former Board Member of the Canadain Ophthalmological Society. He is a Diplomat of the American Board of Ophthalmologists and member of the American Society of Retina Surgeons. He is a founding and standing member of the Can-PAT committee for the Canadian Retina Society

His main areas of research are Inherited Retinal Disorders, Surgical Treatment of Advanced Diabetic Retinopathy and anti-VEGF Agents in the Treatment of Retinovascular Disease. He has also been volunteer faculty for ORBIS International on numerous programs worldwide

 

Financial Disclosure: Dr. Whelan has had a relationship with a for-profit and/or not-for-profit organization do disclose:

  1. AbbVie
  2. Bayer
  3. Novartis

Sessions auxquelles James Whelan participe

Samedi 11 Juin, 2022

Fuseau horaire: (GMT-04:00) Atlantic Time (Canada)
6:30 AM - 8:00 AM | 1 heure 30 minutes
Symposium élaboré conjointement

Objectifs d’apprentissageÀ la fin de la session, les participants pourront :Repérer des propositions canadiennes novatrices de recherche en rétine et les avantages escomptésDécrire comment l’utilisation des innovations numériques en ophtalmologie peut optimiser les soins aux patientsRôles CanMEDS : Érudit, expert médicale Le présent symposium a été élaboré conjointement avec la SCO et Bayer de man...

6:30 AM - 6:40 AM | 10 minutes
RétineSymposium élaboré conjointement
6:47 AM - 6:55 AM | 8 minutes
RétineSymposium élaboré conjointement
7:02 AM - 7:10 AM | 8 minutes
RétineSymposium élaboré conjointement
7:17 AM - 7:25 AM | 8 minutes
RétineSymposium élaboré conjointement
3:45 PM - 5:15 PM | 1 heure 30 minutes
Rétine

Learning ObjectivesAt the end of this session, participants will be able to:Describe prognostication for uveal melanomaApply real word data to the management of macular degeneration, diabetic macular edemaAssess patient experiences of inherited retinal diseasesCanMEDS Roles: Medical Expert, Scholar